Another year at the Endocrine Society has drawn to a close. I’m always impressed – and somewhat amazed – by the sheer volume of activities, resources, and advocacy that our organization produces over a 12-month period.
I’d like to recap some highlights from 2025!
Meetings: Making Connections Between Members and Ideas
Meetings lie at the heart of our mission as a society. Whether in person or virtual, meetings provide the perfect opportunities for learning, networking, mentoring, and advancing our overall profession.
Our meetings are all about making connections and finding your people.
Nowhere are these multiple goals more evident than at ENDO, which, this year, took place in the beautiful city of San Francisco.
More than 7,000 attendees gathered from around the world, July 12-15, to take in 200-plus educational sessions, three plenary sessions, 75-plus symposia sessions, 40-plus Meet the Professor sessions, four Master Clinician panels, and six Meet the Scientist sessions.
Our ever-expanding ENDOExpo hall hosted more than 2,500 scientific posters and was the site of many social and networking activities.
From the ENDO abstracts, we launched a video series featuring 17 authors discussing the latest research on obesity, diabetes, reproductive health, puberty, cancer, and endocrine-disrupting chemicals. The videos have racked up nearly 54,000 views on our Instagram, Facebook, and YouTube channels as of mid-November.
We all look forward now to ENDO 2026 in Chicago, June 13 – 16.
While ENDO is our biggest meeting each year, not to be overlooked are our third-quarter meetings.
Endocrine Review Board (EBR) 2025, held September 5 – 7, is considered the gold standard in preparing rising endocrinologists for the board examination. And Clinical Endocrinology Update (CEU) 2025, held October 23-25, offered sessions on the latest advancements in hormone care across nine topical tracks. Both meetings were widely attended and broadly praised by attendees.
Also in the realm of meetings are the Society’s highly popular Fellows programs.
The Type 1 Diabetes Fellows conference, July 10 – 11, is designed for endocrine fellows as they begin careers as practicing clinicians and diabetes experts. The in-person and online resources included educational and career development opportunities for building practical knowledge, skills, and a lasting network of colleagues.
The Obesity Fellows program, held September 19-20, included in-person educational and leadership programming at our headquarters in Washington, DC, as well as six on-demand lectures with related pre- and post-test questions covering foundational topics on obesity clinical practice.
Fostering Science and Sharing Research
This year, we also took steps to create a new series of meetings for our research members.
In September, we issued a call for proposals on what we call “Science Summits.’These small meetings, of no more than 200 attendees, will serve the educational and collaborative needs of basic and clinical scientists.
Advocacy is another foundation of the Society. Well known on Capitol Hill, our advocacy staff and volunteer leaders have played a leading role in some of the biggest healthcare issues of the day, including insulin affordability and funding of the National Institutes of Health (NIH).
In today’s uncertain research environment, we recognize the need to provide forums where scientists can gather and discuss topics that advance endocrine and related knowledge.
Stay tuned for exciting information on these events.
The Society also remains focused on expanding opportunities for our research members to share their knowledge.
On July 9, we issued a Scientific Statementthat proposes research into the development of new and improved treatment options for people with type 1 diabetes.
Additionally, our suite of five scientific journals remains the top destination for scientists publishing research on hormone conditions and diseases. Together, the Society journals published roughly 1,700 articles in 2025.
To expand research opportunities, the Society’s publisher Oxford University Press (OUP) this year established Read and Publish agreements with hundreds of institutions worldwide that provide funding for Open Access publication.
And in August, the Society extended a benefit to Global Endocrine Leadership Coalition (GELC) member organizations, previously available only to Endocrine Society members, allowing individual members of GELC societies to incur no fees to publish under a standard license in Endocrinology, the Society’s flagship basic science journal.
We’ve also marked a milestone in our podcasts that focus on the latest clinical and research advances. The Endocrine News Podcast marked its 100th episode and is well on its way to the next milestone. And our Endocrine Feedback Loop podcast passed its 65th episode talking to leading endocrine scientists about recent journal articles.
Guiding the Profession
Another area where the Society plays an indispensable role is in the issuing and updating of Clinical Practice Guidelines. In 2025, we updated two important CPGs.
“Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline,”published July 12, recommends that women with diabetes receive proper preconception care and access to emerging diabetes technology and therapeutics to manage their blood sugar before, during, and after pregnancy.
“Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline,” published July 15, calls for more widespread screening of primary aldosteronism, which is known to cause high blood pressure. The CPG noted that an estimated 5% to 14% of people with high blood pressure, seen in primary care, and up to 30% of people, seen in referral centers, have primary aldosteronism.
Advocating for our Profession and Healthcare
Advocacy is another foundation of the Society. Well known on Capitol Hill, our advocacy staff and volunteer leaders have played a leading role in some of the biggest healthcare issues of the day, including insulin affordability and funding of the National Institutes of Health (NIH).
Here is a sampling of our 2025 advocacy activities:
- Endocrine Society and other associations express disappointment in Supreme Court decision on transgender care that increases the likelihood other states will limit or eliminate families’ and patients’ ability to access medical care. (June 18)
- Endocrine Society’s resolution to improve access to anti-obesity medications is passed by the American Medical Association (AMA) House of Delegates. (June 10)
- Endocrine Society expresses concern over the Department of Health and Human Services’ major restructuring, which threatens scientific progress to drive the economy and improve public health. (March 28)
- Endocrine Society calls for restoration of Diabetes Prevention Program Outcomes Study: The three decades of landmark research into type 2 diabetes prevention abruptly ended this month due to government funding cuts. (March 19)
Meanwhile, our advocacy efforts continue full steam ahead. Members are encouraged to lend their voices to ongoing campaigns on our Take Action page. These include:
- Urging Congress to Immediately Pass Long-Term Telehealth Fix
- Urging Congress Members to Cosponsor the Treat and Reduce Obesity Act
- Urging Congress to Reopen the Government and Protect Funding for NIH in FY 2026
- Telling Congress How Cutting Federal Funding Has Affected Your Work
Learn about these and many other advocacy and policy efforts.
Our voice also is being heard in the media. This year, we secured nearly 10 thousand articles about the Society and research from our journals in health and science news outlets. Top media outlets included NBC, TODAY.com, CNN, HealthDay, and New Scientist.
Growing the Profession
Ensuring a healthy pipeline of new endocrine clinicians and researchers is another key focus of our Society.
Founded in 2024, the Society’s Medical School Engagement Program (MSEP) aims to encourage greater interest among medical students in endocrinology. This year, 11 U.S. universities joined the initial 10 MSEP institutions. The 2025 cohort includes some of the largest and most prestigious schools in the United States.
Other Society initiatives to expand the field of endocrinology also remain extremely popular.
The Early Career Forum once again attracted nearly 120 students, fellows, and residents to participate in the July 11 in-person workshop, which offered career guidance and training from established endocrine professionals.
The ExCEL program drew a maximum of 14 early-career physicians in medicine and science to the April 2-4 workshop in Washington, DC. Sessions addressed topics from financial management and business matters to team building and communicating across settings.
The FLARE program attracted a maximum of 25 graduate students, postdoctoral and clinical fellows, and junior faculty to an in-person workshop, March 13-15 in San Diego, California. The program teaches the “business of research” and the leadership skills needed to establish successful research careers.
The Research Experiences for Graduate and Medical Students (REGMS) program, held for eight weeks over July and August 2025, offered a maximum of 14 first-to-third-year medical or graduate students to take part in a comprehensive endocrine research experience. Participants engaged in collaborative lab work, received expert mentorship, built professional networks, and enhanced their professional skills through year-round activities.
Boosting Membership Engagement
Last, but certainly not least, the Society exists to boost you, the member. I’m proud to point out several important efforts this year that helped members advance their careers.
Among them is our expanding list of Special Interest Groups (SIGs). In September, we launched our latest one, the Women’s Health SIG.
This SIG joins our Adrenal and Pituitary SIG, Bone & Mineral SIG, Early Career SIG, Endocrine-Disrupting Chemicals SIG, Endocrine Cancers SIG, Entrepreneurship SIG, Neuroendocrinology SIG, Obesity SIG, Oncoendocrinology SIG, and Transgender Research and Medicine SIG.
Collectively, the SIGs have held dozens of webinars on their specific topics. These events allow members to actively engage with like-minded colleagues, and to expand their knowledge and networks.
To better foster such dialogue among SIG members and others, we recently moved our EndoForum online community to a more user-friendly platform called Hivebrite. Here you can connect instantly with peers across the globe, engage in meaningful discussions, and exchange insights that elevate your work.
As always, this is just a taste of the many things our Society does for members and the field. I look forward to an exciting 2026!
Loading ...